Page last updated: 2024-09-05

sk&f 99085 and Bone Loss, Osteoclastic

sk&f 99085 has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bentzen, CL; Chantry, A; Croucher, PI; Edwards, CM; Guyon-Gellin, Y; Mueller, G; Niesor, EJ; Perry, M; Roelofs, AJ; Russell, RG; Van Camp, B; Vanderkerken, K	1

Other Studies

1 other study(ies) available for sk&f 99085 and Bone Loss, Osteoclastic

Article	Year
Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo. International journal of cancer, 2007, Apr-15, Volume: 120, Issue:8 Topics: Animals; Apoptosis; Bone Density; Bone Resorption; Diphosphonates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Multiple Myeloma; Osteoclasts; Paraproteins; Tumor Cells, Cultured	2007

Article

Year

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

International journal of cancer, 2007, Apr-15, Volume: 120, Issue:8

Topics: Animals; Apoptosis; Bone Density; Bone Resorption; Diphosphonates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Multiple Myeloma; Osteoclasts; Paraproteins; Tumor Cells, Cultured

2007